{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:17:15Z","timestamp":1783138635992,"version":"3.54.6"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.2169\/internalmedicine.6538-25","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:06:24Z","timestamp":1763589984000},"page":"1805-1809","source":"Crossref","is-referenced-by-count":0,"title":["Splenic Artery Aneurysm Associated with Myelofibrosis Managed by Coil Embolization"],"prefix":"10.2169","volume":"65","author":[{"given":"Itaru","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan"},{"name":"Division of Blood Transfusion and Cell Therapy, Ehime University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan"},{"name":"Division of Blood Transfusion and Cell Therapy, Ehime University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuto","family":"Takenaka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Arber DA, Orazi A, Hasserjian RP, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140: 1200-1228, 2022.","DOI":"10.1182\/blood.2022015850"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol 23: 8520-8530, 2005.","DOI":"10.1200\/JCO.2004.00.9316"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Abu-Hilal M, Tawaker J. Portal hypertension secondary to myelofibrosis with myeloid metaplasia: a study of 13 cases. World J Gastroenterol 15: 3128-3133, 2009.","DOI":"10.3748\/wjg.15.3128"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tremblay D, Mascarenhas J. Pharmacotherapeutic advances for splenomegaly in myelofibrosis. Expert Opin Pharmacother 24: 577-585, 2023.","DOI":"10.1080\/14656566.2023.2192350"},{"key":"5","unstructured":"5. Lukie BE, Card RT. Portal hypertension complicating myelofibrosis: reversal following splenectomy. Can Med Assoc J 117: 771-772, 1977."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takahashi N, Takenaka K, Iriyama N, et al. JSH practical guidelines for hematological malignancies, 2023: leukemia-4. Chronic myeloid leukemia (CML)\/myeloproliferative neoplasms (MPN). Int J Hematol. 121: 5-38, 2025.","DOI":"10.1007\/s12185-024-03865-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pasha SF, Gloviczki P, Stanson AW, Kamath PS. Splanchnic artery aneurysms. Mayo Clin Proc 82: 472-479, 2007.","DOI":"10.4065\/82.4.472"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chaer RA, Abularrage CJ, Coleman DM, et al. The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms. J Vasc Surg 72: 3S-39S, 2020.","DOI":"10.1016\/j.jvs.2020.01.039"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Yokokawa T, Misaka T, Kimishima Y, et al. Crucial role of hematopoietic <i>JAK2<\/i> V617F in the development of aortic aneurysms. Haematologica 106: 1910-1922, 2021.","DOI":"10.3324\/haematol.2020.264085"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Obel LM, Skovbo JS, Diederichsen ACP, et al. Aortic aneurysm risk and the somatic <i>JAK2<\/i><sup><i>V617F<\/i><\/sup> mutation: insights from a multicenter, population-based cardiovascular screening study. Circulation 152: 300-312, 2025.","DOI":"10.1161\/CIRCULATIONAHA.125.074002"},{"key":"11","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","volume":"15","author":"F Passamonti","year":"2010","unstructured":"11. Passamonti F, Cervantes F, Vannucchi AM, et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood. 15: 1703-1708, 2010.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Law NL, Villada FA, Kruse MJ. Rupture of splenic artery aneurysm in a man with polycythemia vera and acquired von Willebrand syndrome. BMJ Case Rep 14: e243316, 2021.","DOI":"10.1136\/bcr-2021-243316"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Toros AB, Gokcay S, Cetin G, Ar MC, Karagoz Y, Kesici B. Portal hypertension and myeloproliferative neoplasms: a relationship revealed. ISRN Hematol 2013: 673781, 2013.","DOI":"10.1155\/2013\/673781"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Waldron C, Zafar MA, Ma D, et al. Somatic variants acquired later in life associated with thoracic aortic aneurysms: <i>JAK2<\/i> V617F. Genes (Basel) 15: 883, 2024.","DOI":"10.3390\/genes15070883"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Santos FP, Tam CS, Kantarjian H, et al. Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation. Leuk Lymphoma 55: 121-127, 2014.","DOI":"10.3109\/10428194.2013.794269"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mesa RA, Elliott MA, Tefferi A. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia. Blood Rev 14: 121-129, 2000.","DOI":"10.1054\/blre.2000.0132"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/13\/65_6538-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:31:24Z","timestamp":1783135884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/13\/65_6538-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":16,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6538-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"6538-25"}}